The results showed that the expression of ZBP1 and CASP1 in PRAD tissues was significantly lower than that in the BPH group, while the expression levels of CASP6 and RIPK1 were not different between the two groups (Figures 3A and S3C). This evidence concerns the gene ZBP1 and prostate adenocarcinoma.